There’s less than one week to vote for Medpace for the SCRS Eagle Award! The award recognizes a Sponsor and CRO that demonstrate outstanding leadership, professionalism, integrity, and best practices that advance clinical research through strong site partnerships. At Medpace, we acknowledge that trusted site relationships are critical to our mission of accelerating the development of safe and effective medical therapeutics. If you’ve had a positive experience working with Medpace, we’d be honored to receive your vote: https://xmrrwallet.com/cmx.plnkd.in/gZTQEcY5
Medpace
Pharmaceutical Manufacturing
Cincinnati, OH 294,873 followers
Accelerating Drug, Biologic and Medical Device Clinical Development
About us
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 43 countries.
- Website
-
http://xmrrwallet.com/cmx.pwww.medpace.com
External link for Medpace
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Cincinnati, OH
- Type
- Public Company
- Founded
- 1992
- Specialties
- Early Phase Clinical Research, Phase II-III Clinical Research, RWE-Late Phase Clinical Research, Medical Device and Diagnostics, Regulatory Affairs, Medical Writing, Clinical Monitoring, Clinical Trial Management, Biostatistics and Data Sciences, Drug Safety and Pharmacovigilance, Quality Assurance, Central Laboratories, Bioanalytical Laboratories, Imaging & ECG Core Labs, Oncology clinical development, Nephrology clinical development, Neuroscience clinical development, Infectious Disease clinical development, Cardiovascular clinical development, Metabolic and endocrine clinical development, Rare disease clinical development, Cell and gene therapy clinical development, and Radiopharmaceuticals
Locations
-
Primary
Get directions
5375 Medpace Way
Cincinnati, OH 45227, US
Employees at Medpace
Updates
-
In a newly released case study, Medpace experts explore a Phase III registrational trial for a new class of antibiotic for the treatment of uncomplicated urinary tract infections. Download the case study to discover strategies for rapid site activation, streamlined trial operations, and minimizing patient and site burden—key factors in achieving a seamless and successful trial: https://xmrrwallet.com/cmx.plnkd.in/gfs7hvgh
-
-
Lung cancer is the leading cause of cancer-related death worldwide, yet advances in precision medicine, targeted therapies, and immuno-oncology are changing the trajectory. On #WorldLungCancerDay, we stand with the patients, advocates, and biopharma innovators working to bring new hope to those impacted. At Medpace, our oncology team supports the development of novel lung cancer therapies through deep scientific expertise, embedded medical leadership, and global operational execution. Learn how we can accelerate progress in lung cancer research today: https://xmrrwallet.com/cmx.pbit.ly/4hI0whn
-
-
It's National Intern Day! The Medpace Internship Program fosters a collaborative environment that supports both interns and their mentors. In this Q&A, hear from two current Medpace interns and their mentors as they share insights into their experiences in the program. Kickstart your professional career in clinical research and join our intern team: https://xmrrwallet.com/cmx.pbit.ly/3YWjlHH
-
Wearables and other patient-centric portable devices that remotely collect individual biometric data are transforming clinical trials. As a full-service CRO, Medpace offers comprehensive support by seamlessly collecting, harmonizing, and integrating data from wearables and remote devices into your study. Explore our #wearable #biosensor technology capabilities: https://xmrrwallet.com/cmx.plnkd.in/gXaJRaHN
-
Over the weekend, Medpace associates at our Cincinnati headquarters gathered at the greens for our annual golf outing! Numerous teams battled for the gold while enjoying some friendly competition. Join our winning team and apply to kickstart your clinical research career: https://xmrrwallet.com/cmx.pbit.ly/3YWjlHH #WorkAtMedpace
-
-
-
-
-
+1
-
-
Today, on National Schizophrenia Awareness Day, we reaffirm our commitment to advancing mental health through innovative clinical research. At Medpace, we understand the complexity of schizophrenia and the need for effective treatment options. As a full-service CRO with deep neuroscience expertise and a proven track record of success, we streamline even the most complex global trials in #psychiatry. Connect with our cross-functional team of neuroscience experts to learn more: https://xmrrwallet.com/cmx.plnkd.in/g4ycEtng
-
In the July edition of our Monthly Role Spotlight blog series, take a deep dive into the role of Jackie Elia, Accountant at Medpace. From expert advice to real internship experiences, discover more about the #accountant role in our recently published blog: https://xmrrwallet.com/cmx.plnkd.in/ghzpPnZr #WorkAtMedpace
-
Medpace is delighted to announce the prolongation of our partnership with Centre d'Essais Précoces en Cancérologie de Marseille (CEPCM), which has been part of the Medpace Flagship Site Program for 6 years now! Thank you to the team for their hard work, excellence, and commitment to delivering high-quality data, contributing to accelerating the global development of safe and effective medical therapeutics. Learn more about how Medpace optimizes global site selection and patient engagement for our Sponsors: https://xmrrwallet.com/cmx.plnkd.in/gdtmrS82
-
-
Medpace Reports Second Quarter 2025 Results: https://xmrrwallet.com/cmx.plnkd.in/gyVicP6k